Future nanomedical devices and systems will have strong potential to enable a broad range of aerospace and space applications. With further dimensional reductions in conjunction with the increased capabilities of nanoelectronics and artificial intelligence (AI), nanomedicine may facilitate the development of a wide array of advanced nanomedical diagnostic and therapeutic capabilities dedicated to the health and well being of future astronauts and space pioneers, the inhabitants of future Lunar and Mars colonies, and deep space explorers. These nanomedical innovations may form the core elements of advanced extravehicular space suits that have numerous advantages, such as continuous real-time health monitoring, virtually instantaneous in situ diagnostics, the auto-administration of therapeutics, and the capacities to address serious accidental circumstances and performance of emergency interventions.

These capabilities would contribute significantly to ensuring optimal astronaut health and the provision of quick responses to practically any health-associated issues that may occur when astronauts don their space suits to conduct space walks.  Further out, they will have considerable utility in the support of potentially extended exploratory terrestrial missions on the Moon and Mars. The integration of dynamic nanomedical suites on board spacecraft will also have substantial advantages, as envisaged nanomedical platforms will represent the ultimate in terms of being extremely compact and lightweight for space travel.  Yet, they will be “highly sophisticated, dynamic, and medically powerful with practical utility to rapidly and effectively address virtually any conceivable medical issue or emergency.” (excerpt from Chapter 16 – F. Boehm, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions).

Nanomedical systems may align very well with the requirements of future Moon and Mars colonies in that they will represent a minimal burden on the extremely tight spatial constraints of early colonies.  They will offer an extensive range of highly sophisticated diagnostic and therapeutic capabilities, coupled with powerful AI that is endowed with evolutionary and deductive reasoning, which will have utility in those cases where unidentified Lunar or Martian constituents are suspected as being the causative agents of a particular condition.

“Although the nanomedical capabilities of extravehicular space suits will initially operate from strategically positioned nodes via dermal interfacing membranes, or from within the “second skins” wherein they reside, ultimately they might be designed to imperceptibly meld within the physical bodies of the astronauts themselves. An elegant array of circulating nanodevices and/or static subdermally self-implanting nanomedical reservoirs that are resident at the
periphery of astronauts’ bodies will for the most part sustain a “standby” status. However, they will instantaneously implement appropriate countermeasures in response to any detected form of insult to their accommodating “host.” In essence, they would cumulatively operate to serve as an enhanced, highly sensitive “damage immunity” system “on steroids.””(excerpt from Chapter 16 – F. Boehm, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions)


Recent News

A nanowire array to screen drugs for neurodegenerative diseases

February 22nd, 2018|0 Comments

Using resources at the Center for Integrated Nanotechnologies (CINT), a team built tiny wires that can record the electrical activity of neurons in fine detail (Nano Letters, "High density individually [...]

Nanoparticles act as surgical blades for improved dental surgery

February 21st, 2018|0 Comments

Currently, more than 80 nanotechnologies have been approved for a variety of medical applications, from treating cancer to bioimaging to tissue remodeling. Now in a new study, researchers have shown [...]

A synthetic cell that produces anti-cancer drugs within a tumor

February 20th, 2018|0 Comments

Technion-Israel Institute of Technology researchers have successfully treated a cancerous tumor using a "nano-factory" – a synthetic cell that produces anti-cancer proteins within the tumor tissue. The research, which was [...]

Long-Term Delivery of Nanomedicines

February 19th, 2018|0 Comments

A good deal of the field of nanomedicine is focused on delivering drugs to specific sites within the body, such as specific organs or cancer tumors. While many nanomedicines have [...]

VR Allows Scientists to Walk Through Cancer Cells

February 18th, 2018|0 Comments

UNSW researchers are revolutionising medical research by creating virtual reality technology that allows scientists to walk around the landscape of human cells. Ground-breaking virtual reality technology is allowing multiple scientists [...]

Medical devices vulnerable to cyberattacks

February 17th, 2018|0 Comments

Medical devices, such as computed tomography (CT) and magnetic resonance imaging (MRI) machines, are vulnerable to cyberattacks if they are not given regular security updates. Researchers from the Ben-Gurion University [...]


About NanoApps Medical Inc

NanoApps Medical, Inc. was incorporated by Frank Boehm in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds.

The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Boehm is now compiling a book that will articulate this grand vision.

Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.

Read More